243 related articles for article (PubMed ID: 28650484)
1. Insertional mutagenesis identifies drivers of a novel oncogenic pathway in invasive lobular breast carcinoma.
Kas SM; de Ruiter JR; Schipper K; Annunziato S; Schut E; Klarenbeek S; Drenth AP; van der Burg E; Klijn C; Ten Hoeve JJ; Adams DJ; Koudijs MJ; Wesseling J; Nethe M; Wessels LFA; Jonkers J
Nat Genet; 2017 Aug; 49(8):1219-1230. PubMed ID: 28650484
[TBL] [Abstract][Full Text] [Related]
2. Epigenetic and genetic alterations of APC and CDH1 genes in lobular breast cancer: relationships with abnormal E-cadherin and catenin expression and microsatellite instability.
Sarrió D; Moreno-Bueno G; Hardisson D; Sánchez-Estévez C; Guo M; Herman JG; Gamallo C; Esteller M; Palacios J
Int J Cancer; 2003 Aug; 106(2):208-15. PubMed ID: 12800196
[TBL] [Abstract][Full Text] [Related]
3. E-cadherin immunohistochemical expression in invasive lobular carcinoma of the breast: correlation with morphology and CDH1 somatic alterations.
Grabenstetter A; Mohanty AS; Rana S; Zehir A; Brannon AR; D'Alfonso TM; DeLair DF; Tan LK; Ross DS
Hum Pathol; 2020 Aug; 102():44-53. PubMed ID: 32599083
[TBL] [Abstract][Full Text] [Related]
4. Modeling invasive lobular breast carcinoma by CRISPR/Cas9-mediated somatic genome editing of the mammary gland.
Annunziato S; Kas SM; Nethe M; Yücel H; Del Bravo J; Pritchard C; Bin Ali R; van Gerwen B; Siteur B; Drenth AP; Schut E; van de Ven M; Boelens MC; Klarenbeek S; Huijbers IJ; van Miltenburg MH; Jonkers J
Genes Dev; 2016 Jun; 30(12):1470-80. PubMed ID: 27340177
[TBL] [Abstract][Full Text] [Related]
5. Epigenetic silencing in non-neoplastic epithelia identifies E-cadherin (CDH1) as a target for chemoprevention of lobular neoplasia.
Zou D; Yoon HS; Perez D; Weeks RJ; Guilford P; Humar B
J Pathol; 2009 Jun; 218(2):265-72. PubMed ID: 19294736
[TBL] [Abstract][Full Text] [Related]
6. Truncated ASPP2 Drives Initiation and Progression of Invasive Lobular Carcinoma via Distinct Mechanisms.
Schipper K; Drenth AP; van der Burg E; Cornelissen S; Klarenbeek S; Nethe M; Jonkers J
Cancer Res; 2020 Apr; 80(7):1486-1497. PubMed ID: 32060147
[TBL] [Abstract][Full Text] [Related]
7. ERBB2 mutation is associated with a worse prognosis in patients with CDH1 altered invasive lobular cancer of the breast.
Ping Z; Siegal GP; Harada S; Eltoum IE; Youssef M; Shen T; He J; Huang Y; Chen D; Li Y; Bland KI; Chang HR; Shen D
Oncotarget; 2016 Dec; 7(49):80655-80663. PubMed ID: 27811364
[TBL] [Abstract][Full Text] [Related]
8. Targeted capture massively parallel sequencing analysis of LCIS and invasive lobular cancer: Repertoire of somatic genetic alterations and clonal relationships.
Sakr RA; Schizas M; Carniello JV; Ng CK; Piscuoglio S; Giri D; Andrade VP; De Brot M; Lim RS; Towers R; Weigelt B; Reis-Filho JS; King TA
Mol Oncol; 2016 Feb; 10(2):360-70. PubMed ID: 26643573
[TBL] [Abstract][Full Text] [Related]
9. PTEN Loss in E-Cadherin-Deficient Mouse Mammary Epithelial Cells Rescues Apoptosis and Results in Development of Classical Invasive Lobular Carcinoma.
Boelens MC; Nethe M; Klarenbeek S; de Ruiter JR; Schut E; Bonzanni N; Zeeman AL; Wientjens E; van der Burg E; Wessels L; van Amerongen R; Jonkers J
Cell Rep; 2016 Aug; 16(8):2087-2101. PubMed ID: 27524621
[TBL] [Abstract][Full Text] [Related]
10. Inter-observer agreement for the histological diagnosis of invasive lobular breast carcinoma.
Christgen M; Kandt LD; Antonopoulos W; Bartels S; Van Bockstal MR; Bredt M; Brito MJ; Christgen H; Colpaert C; Cserni B; Cserni G; Daemmrich ME; Danebrock R; Dedeurwaerdere F; van Deurzen CH; Erber R; Fathke C; Feist H; Fiche M; Gonzalez CA; Ter Hoeve ND; Kooreman L; Krech T; Kristiansen G; Kulka J; Laenger F; Lafos M; Lehmann U; Martin-Martinez MD; Mueller S; Pelz E; Raap M; Ravarino A; Reineke-Plaass T; Schaumann N; Schelfhout AM; De Schepper M; Schlue J; Van de Vijver K; Waelput W; Wellmann A; Graeser M; Gluz O; Kuemmel S; Nitz U; Harbeck N; Desmedt C; Floris G; Derksen PW; van Diest PJ; Vincent-Salomon A; Kreipe H
J Pathol Clin Res; 2022 Mar; 8(2):191-205. PubMed ID: 34889530
[TBL] [Abstract][Full Text] [Related]
11. Germline CDH1 mutations in bilateral lobular carcinoma in situ.
Petridis C; Shinomiya I; Kohut K; Gorman P; Caneppele M; Shah V; Troy M; Pinder SE; Hanby A; Tomlinson I; Trembath RC; Roylance R; Simpson MA; Sawyer EJ
Br J Cancer; 2014 Feb; 110(4):1053-7. PubMed ID: 24366306
[TBL] [Abstract][Full Text] [Related]
12. Novel markers for differentiation of lobular and ductal invasive breast carcinomas by laser microdissection and microarray analysis.
Turashvili G; Bouchal J; Baumforth K; Wei W; Dziechciarkova M; Ehrmann J; Klein J; Fridman E; Skarda J; Srovnal J; Hajduch M; Murray P; Kolar Z
BMC Cancer; 2007 Mar; 7():55. PubMed ID: 17389037
[TBL] [Abstract][Full Text] [Related]
13. Microenvironment-induced restoration of cohesive growth associated with focal activation of P-cadherin expression in lobular breast carcinoma metastatic to the colon.
Gronewold M; Grote I; Bartels S; Christgen H; Kandt LD; Brito MJ; Cserni G; Daemmrich ME; Fogt F; Helmke BM; Ter Hoeve N; Lang-Schwarz C; Vieth M; Wellmann A; Kuehnle E; Kulik U; Riedel G; Reineke-Plaass T; Lehmann U; Koorman T; Derksen PW; Kreipe H; Christgen M
J Pathol Clin Res; 2024 Mar; 10(2):e12361. PubMed ID: 38618992
[TBL] [Abstract][Full Text] [Related]
14. Relapsed classic E-cadherin (CDH1)-mutated invasive lobular breast cancer shows a high frequency of HER2 (ERBB2) gene mutations.
Ross JS; Wang K; Sheehan CE; Boguniewicz AB; Otto G; Downing SR; Sun J; He J; Curran JA; Ali S; Yelensky R; Lipson D; Palmer G; Miller VA; Stephens PJ
Clin Cancer Res; 2013 May; 19(10):2668-76. PubMed ID: 23575477
[TBL] [Abstract][Full Text] [Related]
15. Rebalancing of actomyosin contractility enables mammary tumor formation upon loss of E-cadherin.
Schipper K; Seinstra D; Paulien Drenth A; van der Burg E; Ramovs V; Sonnenberg A; van Rheenen J; Nethe M; Jonkers J
Nat Commun; 2019 Aug; 10(1):3800. PubMed ID: 31444332
[TBL] [Abstract][Full Text] [Related]
16. Lobular breast cancer: molecular basis, mouse and cellular models.
Christgen M; Derksen P
Breast Cancer Res; 2015 Feb; 17(1):16. PubMed ID: 25757734
[TBL] [Abstract][Full Text] [Related]
17. E-cadherin inactivation in lobular carcinoma in situ of the breast: an early event in tumorigenesis.
Vos CB; Cleton-Jansen AM; Berx G; de Leeuw WJ; ter Haar NT; van Roy F; Cornelisse CJ; Peterse JL; van de Vijver MJ
Br J Cancer; 1997; 76(9):1131-3. PubMed ID: 9365159
[TBL] [Abstract][Full Text] [Related]
18. Mammary-specific inactivation of E-cadherin and p53 impairs functional gland development and leads to pleomorphic invasive lobular carcinoma in mice.
Derksen PW; Braumuller TM; van der Burg E; Hornsveld M; Mesman E; Wesseling J; Krimpenfort P; Jonkers J
Dis Model Mech; 2011 May; 4(3):347-58. PubMed ID: 21282721
[TBL] [Abstract][Full Text] [Related]
19. Hsa-miR-375 is differentially expressed during breast lobular neoplasia and promotes loss of mammary acinar polarity.
Giricz O; Reynolds PA; Ramnauth A; Liu C; Wang T; Stead L; Childs G; Rohan T; Shapiro N; Fineberg S; Kenny PA; Loudig O
J Pathol; 2012 Jan; 226(1):108-19. PubMed ID: 21953071
[TBL] [Abstract][Full Text] [Related]
20. Multiple ways of silencing E-cadherin gene expression in lobular carcinoma of the breast.
Droufakou S; Deshmane V; Roylance R; Hanby A; Tomlinson I; Hart IR
Int J Cancer; 2001 May; 92(3):404-8. PubMed ID: 11291078
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
